Classification of drugs for teratogenic risk: An anachronistic way of counseling [5]

Teratology

Volumn 66, Issue 2, 2002, Pages 61-62

  Merlob, Paul ^a,b   Stahl, Bracha ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; DRUG; TERATOGENIC AGENT;

DRUG CLASSIFICATION; FOOD AND DRUG ADMINISTRATION; LETTER; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TERATOGENICITY; ATTITUDE TO HEALTH; CLASSIFICATION; CONGENITAL MALFORMATION; FEMALE; GENETIC COUNSELING; HUMAN; PERCEPTION; RISK ASSESSMENT;

ABNORMALITIES, DRUG-INDUCED; ATTITUDE TO HEALTH; FEMALE; GENETIC COUNSELING; HUMAN; PERCEPTION; PHARMACEUTICAL PREPARATIONS; PREGNANCY; RISK ASSESSMENT; TERATOGENS; HUMANS;

EID: 0036022052     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10069     Document Type: Letter

References (14)

1. Risk classification systems for drug use during pregnancy. Are they a reliable source of information?
2. Classification of drugs for teratogenic risk
3. Committee on drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn
4. Potential human teratogenicity of frequently prescribed drugs
5. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)
6. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac)
7. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS)
8. More on drugs and pregnancy
9. FDA classification of drugs for teratogenic risk